BiotechTube
Home/Novasenta/Michael Lyman, PhD
ML

Michael Lyman, PhD

CEO

Novasenta

Therapeutic Areas

OncologyImmune-mediated Diseases

Novasenta Pipeline

DrugIndicationPhase
UndisclosedCancer and/or Immune-mediated DiseasesPreclinical

Leadership Team at Novasenta

JY
Jiayi Yu, PhD
VP Development & Operations
View full Novasenta profile